Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Marcellin

Showing results (201-210 of 212) with videos related to

Pageof 22
Sort By:
Hepatology (Baltimore, Md.)|July 1, 1999
Interferon alfa for chronic hepatitis B infection: increased efficacy of prolonged treatment. The European Concerted Action on Viral Hepatitis (EUROHEP)H L Janssen, G Gerken, V Carreño, et al.
Epidemiology and Infection|August 1, 2019
Hepatitis C subtype distribution in chronically infected patients with mild liver fibrosis in France: the GEMHEP studyT Semenova, B Nemoz, V Thibault, et al.
Hepatology (Baltimore, Md.)|November 3, 2011
Shorter durations and lower doses of peginterferon alfa-2a are associated with inferior hepatitis B e antigen seroconversion rates in hepatitis B virus genotypes B or CY-F Liaw, J-D Jia, H L Y Chan, et al.
Journal of Viral Hepatitis|May 20, 2003
Reinforced interferon alpha-2b and ribavirin is more effective than standard combination therapy in the retreatment of chronic hepatitis C previously nonresponsive to interferon: a randomized trialT Poynard, P Marcellin, A Bissery, et al.
Alimentary Pharmacology & Therapeutics|October 11, 2017
The negative impact of HBV/HCV coinfection on cirrhosis and its consequencesS Pol, G Haour, H Fontaine, et al.
Journal of Clinical Microbiology|December 17, 1997
GEMHEP multicenter quality control study of PCR detection of GB virus C/hepatitis G virus RNA in serumM Bogard, C Buffet-Janvresse, J F Cantaloube, et al.
Journal of Virological Methods|March 15, 2000
Lessons from a multicentre study of the detectability of viral genomes based on a two-round quality control of GB virus C (GBV-C)/hepatitis G virus (HGV) polymerase chain reaction assayJ J Lefrère, J Lerable, M Mariotti, et al.
Journal of Viral Hepatitis|July 2, 2013
Long-term clearance of hepatitis C virus following interferon α-2b or peginterferon α-2b, alone or in combination with ribavirinM P Manns, P J Pockros, G Norkrans, et al.
Journal of Viral Hepatitis|August 10, 2011
The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*A Hatzakis, S Wait, J Bruix, et al.
Alimentary Pharmacology & Therapeutics|September 16, 2016
Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa-2a combination therapy for chronic hepatitis BP Marcellin, S H Ahn, W-L Chuang, et al.
Pageof 22

Showing results (201-210 of 212) with videos related to

Sort By:
Pageof 22
Hepatology (Baltimore, Md.)|July 1, 1999
Interferon alfa for chronic hepatitis B infection: increased efficacy of prolonged treatment. The European Concerted Action on Viral Hepatitis (EUROHEP)H L Janssen, G Gerken, V Carreño, et al.
Epidemiology and Infection|August 1, 2019
Hepatitis C subtype distribution in chronically infected patients with mild liver fibrosis in France: the GEMHEP studyT Semenova, B Nemoz, V Thibault, et al.
Hepatology (Baltimore, Md.)|November 3, 2011
Shorter durations and lower doses of peginterferon alfa-2a are associated with inferior hepatitis B e antigen seroconversion rates in hepatitis B virus genotypes B or CY-F Liaw, J-D Jia, H L Y Chan, et al.
Journal of Viral Hepatitis|May 20, 2003
Reinforced interferon alpha-2b and ribavirin is more effective than standard combination therapy in the retreatment of chronic hepatitis C previously nonresponsive to interferon: a randomized trialT Poynard, P Marcellin, A Bissery, et al.
Alimentary Pharmacology & Therapeutics|October 11, 2017
The negative impact of HBV/HCV coinfection on cirrhosis and its consequencesS Pol, G Haour, H Fontaine, et al.
Journal of Clinical Microbiology|December 17, 1997
GEMHEP multicenter quality control study of PCR detection of GB virus C/hepatitis G virus RNA in serumM Bogard, C Buffet-Janvresse, J F Cantaloube, et al.
Journal of Virological Methods|March 15, 2000
Lessons from a multicentre study of the detectability of viral genomes based on a two-round quality control of GB virus C (GBV-C)/hepatitis G virus (HGV) polymerase chain reaction assayJ J Lefrère, J Lerable, M Mariotti, et al.
Journal of Viral Hepatitis|July 2, 2013
Long-term clearance of hepatitis C virus following interferon α-2b or peginterferon α-2b, alone or in combination with ribavirinM P Manns, P J Pockros, G Norkrans, et al.
Journal of Viral Hepatitis|August 10, 2011
The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*A Hatzakis, S Wait, J Bruix, et al.
Alimentary Pharmacology & Therapeutics|September 16, 2016
Predictors of response to tenofovir disoproxil fumarate plus peginterferon alfa-2a combination therapy for chronic hepatitis BP Marcellin, S H Ahn, W-L Chuang, et al.
Pageof 22